Opioid use was more common in patients with nonalcoholic fatty liver disease with cirrhosis, higher BMI and psychiatric disease, according to a study published in Digestive Diseases.Healio Gastroenterology spoke with Andrew M. Moon, MD, advanced/ transplant hepatology at the University of North Carolina, about the TARGET-NASH study looking at opioid use in 3,474 patients with NAFLD.Healio: What was the purpose of the study?Moon: We knew that the burden of NAFLD was huge in the United States and we knew from clinical experience that patients with this condition experience painfulRead More